Related Experiment Video
Updated: Aug 29, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
De-Nterm-ining GLP1R signaling bias
Johannes Broichhagen1, David J Hodson2
1Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Abstract:
Biased agonism has emerged as a promising strategy for improving incretin therapeutics, yet the structural determinants of signaling bias remain incompletely understood. Building on their recent parathyroid hormone 1 receptor-β-arrestin structure, Zhao and colleagues identify extracellular loop 3 as a conformational switch controlling glucagon-like peptide-1 receptor transducer selectivity, enabling rational design of biased agonists.
More Related Videos
07:00Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine
Published on: February 26, 2019
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Related Concept Videos
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GPCRs Regulate Adenylyl Cylase Activity
Two...
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway